Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 19.42
0.00 (0.00%)
Mar 9, 2026, 3:04 PM CST
Hualan Biological Vaccine Revenue
Hualan Biological Vaccine had revenue of 746.03M CNY in the quarter ending September 30, 2025, a decrease of -19.07%. This brings the company's revenue in the last twelve months to 976.44M, down -40.80% year-over-year. In the year 2024, Hualan Biological Vaccine had annual revenue of 1.13B, down -53.21%.
Revenue (ttm)
976.44M
Revenue Growth
-40.80%
P/S Ratio
11.83
Revenue / Employee
1.31M
Employees
748
Market Cap
11.55B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 704.16M |
| Beijing Hotgen Biotech | 407.69M |
| Chengzhi | 11.53B |
| HitGen | 525.57M |
| Staidson (Beijing) BioPharmaceuticals | 244.37M |
| InventisBio | 37.33M |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.96B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |